The role of saposin C in Gaucher disease

详细信息	查看全文 | 推荐本文 |

• 作者：Rafael J. Tamargo ^{tamargorj@mail.nih.gov} ; Arash Velayati ^{velayatia@mail.nih.gov} ; Ehud Goldin ^{goldine@mail.nih.gov} ; Ellen Sidransky ; ^{sidranse@mail.nih.gov}
• 关键词：GCase ; glucocerebrosidase ; GD ; Gaucher disease ; PD ; Parkinson disease ; Sap ; saposin ; pSap ; prosaposin ; FRET ; Fö ; rster resonance energy transfer ; NB-DNJ ; N-butyl-deoxynojirimycin ; IFG ; isofagomine ; LIMP-2 ; lysosomal integral membrane protein type 2
• 刊名：Molecular Genetics and Metabolism
• 出版年：2012
• 期刊代码：175_10967192
• 类别：bio
• 出版时间：July, 2012
• 卷：106
• 期：3
• 页码：257-263
• 文件大小：485 K

摘要

Saposin C is one of four homologous proteins derived from sequential cleavage of the saposin precursor protein, prosaposin. It is an essential activator for glucocerebrosidase, the enzyme deficient in Gaucher disease. Gaucher disease is a rare autosomal recessive lysosomal storage disorder caused by mutations in the GBA gene that exhibits vast phenotypic heterogeneity, despite its designation as a 鈥渟imple鈥?Mendelian disorder. The observed phenotypic variability has led to a search for disease modifiers that can alter the Gaucher phenotype. The PSAP gene encoding saposin C is a prime candidate modifier for Gaucher disease. In humans, saposin C deficiency due to mutations in PSAP results in a Gaucher-like phenotype, despite normal in vitro glucocerebrosidase activity. Saposin C deficiency has also been shown to modify phenotype in one mouse model of Gaucher disease. The role of saposin C as an activator required for normal glucocerebrosidase function, and the consequences of saposin C deficiency are described, and are being explored as potential modifying factors in patients with Gaucher disease.